Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Barrington Research Reaffirms Bullish Outlook on ICF International Raises Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Barrington Research reaffirms its bullish outlook on ICF International (NASDAQ: ICFI) on March 4, 2024, raising its price target to $173.00 from $145.00. This adjustment reflects an 11.02% increase from the current share price of $155.83. Analysts collectively view ICF International as a Moderate Buy, with an average price target of $177.50 based on 2 buy ratings. Over the last 3 months, ICFI has garnered 4 Buy Ratings, signaling strong investor confidence in the company’s future performance.

ICF International, Inc. (ICFI) Stock Sees Positive Performance, Indicates Investor Confidence for Future Growth

On March 4, 2024, ICF International, Inc. (ICFI) saw a positive performance in the stock market. The price of ICFI shares increased by $0.93 since the previous market close, representing a 0.60% rise. Despite opening lower at $155.38, the stock climbed throughout the day, indicating investor confidence. ICFI is a global consulting and technology services company known for delivering innovative solutions and driving growth. The positive price momentum and stock trading near its 52-week high suggest further upside potential. Investors should conduct thorough research before making investment decisions.

ICF International (ICFI) Stock Performance Analysis: Positive Growth in Revenue, Net Income, and EPS

On March 4, 2024, ICF International (ICFI) stock had a mixed performance based on the latest financial data provided by CNN Money. The company reported total revenue of $1.96 billion for the past year, with a quarterly revenue of $478.35 million. This represents a 10.3% increase in total revenue since the previous year, but total revenue remained flat compared to the last quarter.

In terms of net income, ICF International reported a net income of $82.61 million for the past year, with a quarterly net income of $22.16 million. Net income increased by 28.59% since the previous year, but like total revenue, it held flat compared to the last quarter.

Earnings per share (EPS) for ICF International were reported at $4.35 for the past year, with a quarterly EPS of $1.16. EPS increased by 28.86% since the previous year, but like total revenue and net income, it remained flat compared to the last quarter.

Overall, the financial performance of ICF International on March 4, 2024, showed positive growth in terms of total revenue, net income, and EPS compared to the previous year. However, the company’s performance held flat compared to the last quarter, indicating a stable but not necessarily improving trend.

Investors and analysts may be interested in monitoring future financial reports from ICF International to see if the company can sustain its growth trajectory and potentially improve its performance in the upcoming quarters. As with any investment, it is important to conduct thorough research and analysis before making any decisions regarding ICF International stock.

Tags: ICFI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance analyst

Anticipating Angel Oak Mortgage REITs Quarterly Earnings March 5 2024

Biotechnology Stock Bull Market

Neurogenes Breakthrough in Rett Syndrome Gene Therapy Trial Expansion and Accelerated Enrollment Plans

financial-data

Full House Resorts NASDAQFLL Quarterly Earnings Preview and Historical Performance

Recommended

Amazon_charge

Positive Outlook for Novo Nordisks Obesity Drug Wegovy and the Future of Obesity Drugs

2 years ago
Food Retailers Stock Market Today

DA Davidson Analyst Reaffirms Buy Rating on Campbell Soup with Lowered Price Target

2 years ago

Everest Re Group Sees Reduction in Stake by Allspring Global Investments Holdings LLC Amidst Strong Financial Performance

2 years ago
Regenxbio Stock

Regenxbio Shares Slide as FDA Pushes Back Key Drug Decision

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Gladstone Capital Executes Strategic Debt Refinancing and Rewards Shareholders

Executive Share Sales and Management Shifts Raise Questions at Repay Holdings

EU Data Act Fuels Momentum for Cybersecurity ETF

Dentsply Sirona’s Rocky Road to Recovery

Trending

BioNTech Stock
Earnings

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

by Andreas Sommer
September 22, 2025
0

The German biotechnology firm BioNTech is navigating a critical strategic transition. Having achieved global recognition through its...

Nestle Stock

Leadership Crisis at Nestlé Sparks Investor Concerns

September 22, 2025
Standex Stock

Standex Shares Plunge Amid Technical Warnings and Insider Selling

September 22, 2025
Synchrony Stock

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

September 22, 2025
Vanguard Information Technology Index Fund ETF Shares Stock

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation
  • Leadership Crisis at Nestlé Sparks Investor Concerns
  • Standex Shares Plunge Amid Technical Warnings and Insider Selling

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com